Polaris Capital Management Raised Brookline Bancorp (BRKL) Stake By $381,000; Taro Pharmaceutical Industries LTD. Ordinary Share (TARO) Shorts Lowered By 19.07%

May 22, 2018 - By Richard Conner

Taro Pharmaceutical Industries LTD. Ordinary Share (NYSE:TARO) had a decrease of 19.07% in short interest. TARO’s SI was 581,400 shares in May as released by FINRA. Its down 19.07% from 718,400 shares previously. With 84,300 avg volume, 7 days are for Taro Pharmaceutical Industries LTD. Ordinary Share (NYSE:TARO)’s short sellers to cover TARO’s short positions. The SI to Taro Pharmaceutical Industries LTD. Ordinary Share’s float is 5.45%. The stock increased 0.04% or $0.04 during the last trading session, reaching $112.01. About 70,409 shares traded. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) has declined 17.38% since May 22, 2017 and is downtrending. It has underperformed by 28.93% the S&P500.

Polaris Capital Management Llc increased Brookline Bancorp Inc (BRKL) stake by 2.26% reported in 2017Q4 SEC filing. Polaris Capital Management Llc acquired 25,400 shares as Brookline Bancorp Inc (BRKL)’s stock rose 1.57%. The Polaris Capital Management Llc holds 1.15 million shares with $18.03M value, up from 1.12 million last quarter. Brookline Bancorp Inc now has $1.43 billion valuation. The stock increased 1.57% or $0.275 during the last trading session, reaching $17.825. About 96,886 shares traded. Brookline Bancorp, Inc. (NASDAQ:BRKL) has risen 6.60% since May 22, 2017 and is uptrending. It has underperformed by 4.95% the S&P500.

Since February 5, 2018, it had 0 insider buys, and 4 insider sales for $784,850 activity. $164,300 worth of Brookline Bancorp, Inc. (NASDAQ:BRKL) was sold by PECK CHARLES H on Tuesday, February 27. The insider HACKETT JOHN A sold $81,250. Another trade for 20,000 shares valued at $329,800 was sold by Fess Darryl J.. Cosman James M also sold $209,500 worth of Brookline Bancorp, Inc. (NASDAQ:BRKL) shares.

More news for Brookline Bancorp, Inc. (NASDAQ:BRKL) were recently published by: Seekingalpha.com, which released: “Brookline Bancorp’s (BRKL) CEO Paul Perrault on Q1 2018 Results – Earnings Call Transcript” on April 29, 2018. Nasdaq.com‘s article titled: “Brookline Bancorp Announces First Quarter Results” and published on April 25, 2018 is yet another important article.

Among 4 analysts covering Brookline Bancorp (NASDAQ:BRKL), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Brookline Bancorp had 16 analyst reports since September 3, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Thursday, October 19 by Keefe Bruyette & Woods. The firm earned “Hold” rating on Monday, October 23 by Piper Jaffray. The firm has “Hold” rating by Keefe Bruyette & Woods given on Thursday, December 21. As per Wednesday, September 16, the company rating was initiated by Piper Jaffray. Keefe Bruyette & Woods maintained Brookline Bancorp, Inc. (NASDAQ:BRKL) rating on Tuesday, August 8. Keefe Bruyette & Woods has “Hold” rating and $15.5000 target. The stock has “Neutral” rating by Compass Point on Friday, November 18. The stock has “Hold” rating by Keefe Bruyette & Woods on Thursday, June 1. The stock has “Buy” rating by Compass Point on Thursday, October 22. The firm has “Hold” rating given on Thursday, September 21 by Piper Jaffray. The stock has “Hold” rating by Keefe Bruyette & Woods on Friday, October 13.

Polaris Capital Management Llc decreased Pinnacle Financial Partners (NASDAQ:PNFP) stake by 8,800 shares to 214,409 valued at $14.22M in 2017Q4. It also reduced Integrated Device Tech Inc (NASDAQ:IDTI) stake by 29,500 shares and now owns 78,339 shares. Deckers Outdoor Corp (NYSE:DECK) was reduced too.

Investors sentiment decreased to 1.06 in Q4 2017. Its down 0.24, from 1.3 in 2017Q3. It worsened, as 21 investors sold BRKL shares while 50 reduced holdings. 28 funds opened positions while 47 raised stakes. 57.14 million shares or 1.40% less from 57.96 million shares in 2017Q3 were reported. Fiduciary Trust reported 91,176 shares or 0.04% of all its holdings. Massachusetts-based Adage Cap Prtnrs Grp Incorporated Ltd Llc has invested 0% in Brookline Bancorp, Inc. (NASDAQ:BRKL). Tiaa Cref Inv Mgmt Limited Liability Co reported 392,187 shares stake. Charter Trust invested in 0.08% or 46,032 shares. Ameritas Prtn owns 0% invested in Brookline Bancorp, Inc. (NASDAQ:BRKL) for 6,592 shares. New York State Teachers Retirement System accumulated 239,696 shares or 0.01% of the stock. Smithfield stated it has 295 shares or 0% of all its holdings. Price T Rowe Associate Md stated it has 42,398 shares or 0% of all its holdings. Cipher Cap LP reported 51,321 shares. Ellington Mngmt Gru Ltd Com, a Connecticut-based fund reported 11,800 shares. Profund Advisors Ltd Limited Liability Company, Maryland-based fund reported 12,024 shares. Northern Tru Corporation has invested 0.01% in Brookline Bancorp, Inc. (NASDAQ:BRKL). Arizona State Retirement stated it has 0.02% in Brookline Bancorp, Inc. (NASDAQ:BRKL). Gemmer Asset Limited Liability Company accumulated 184 shares. Jpmorgan Chase Co accumulated 178,736 shares.

Taro Pharmaceutical Industries Ltd., a science pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in the United States, Canada, Israel, and internationally. The company has market cap of $4.49 billion. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. It has a 21.75 P/E ratio. The firm sells and distributes its products principally to drug industry wholesalers, drug store chains, mass merchandisers, healthcare institutions, and private pharmacies.

Among 2 analysts covering Taro Pharm (NYSE:TARO), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Taro Pharm had 4 analyst reports since May 23, 2017 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, May 15 by H.C. Wainwright. H.C. Wainwright maintained the stock with “Buy” rating in Monday, April 2 report. On Tuesday, May 23 the stock rating was downgraded by Credit Suisse to “Neutral”.

Brookline Bancorp, Inc. (NASDAQ:BRKL) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>